UFP Technologies (NASDAQ:UFPT) Shares Down 7% – Time to Sell?

UFP Technologies, Inc. (NASDAQ:UFPT)’s stock price was down 7% during trading on Wednesday . The company traded as low as $317.86 and last traded at $319.57. Approximately 30,358 shares changed hands during trading, a decline of 50% from the average daily volume of 61,107 shares. The stock had previously closed at $343.64.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital raised their target price on UFP Technologies from $344.00 to $392.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th.

UFP Technologies Price Performance

The stock has a market capitalization of $2.42 billion, a PE ratio of 44.93 and a beta of 0.96. The stock’s 50 day moving average is $310.37 and its two-hundred day moving average is $293.70. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.43 and a current ratio of 2.56.

Insider Activity at UFP Technologies

In related news, CEO R Jeffrey Bailly sold 10,000 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $325.89, for a total value of $3,258,900.00. Following the transaction, the chief executive officer now directly owns 80,044 shares of the company’s stock, valued at approximately $26,085,539.16. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other UFP Technologies news, Director Cynthia L. Feldmann sold 647 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $352.30, for a total value of $227,938.10. Following the transaction, the director now directly owns 4,049 shares of the company’s stock, valued at $1,426,462.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO R Jeffrey Bailly sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $325.89, for a total transaction of $3,258,900.00. Following the completion of the transaction, the chief executive officer now directly owns 80,044 shares in the company, valued at $26,085,539.16. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 23,747 shares of company stock valued at $7,799,015. 6.17% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of UFPT. Northwest Investment Counselors LLC purchased a new stake in shares of UFP Technologies during the 3rd quarter valued at approximately $32,000. EverSource Wealth Advisors LLC raised its position in shares of UFP Technologies by 1,614.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 120 shares of the industrial products company’s stock valued at $30,000 after buying an additional 113 shares during the period. Advisors Asset Management Inc. purchased a new stake in shares of UFP Technologies during the 1st quarter valued at approximately $35,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of UFP Technologies during the 2nd quarter valued at approximately $36,000. Finally, GAMMA Investing LLC raised its position in shares of UFP Technologies by 77.9% during the 3rd quarter. GAMMA Investing LLC now owns 137 shares of the industrial products company’s stock valued at $43,000 after buying an additional 60 shares during the period. 87.28% of the stock is owned by hedge funds and other institutional investors.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.